AF
RCKT icon

Allworth Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Allworth Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1K Sell
8,202
-498
-6% -$1.66K ﹤0.01% 2929
2026
Q1 		$31.1K Buy
8,700
+5,712
+191% +$22.7K ﹤0.01% 2679
2025
Q4 		$10.5K Buy
2,988
+967
+48% +$3.31K ﹤0.01% 3236
2025
Q3 		$6.59K Buy
2,021
+1,381
+216% +$4.35K ﹤0.01% 3385
2025
Q2 		$1.57K Sell
640
-58
-8% -$294 ﹤0.01% 3809
2025
Q1 		$5.19K Buy
698
+675
+2,935% +$6.67K ﹤0.01% 2738
2024
Q4 		$242 Buy
23
+12
+109% +$181 ﹤0.01% 3751
2024
Q3 		$204 Buy
+11
New +$225 ﹤0.01% 3593
2023
Q4 		– Sell
-6
Closed -$123 – 3588
2023
Q3 		$123 Buy
+6
New +$109 ﹤0.01% 3310

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Allworth Financial's RCKT Position: Q2 2026 in Review

Allworth Financial reduced its Rocket Pharmaceuticals (RCKT) stake by 5.7% in Q2 2026, selling an estimated $1.66K and leaving 8,202 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Allworth Financial first reported a position in RCKT in Q3 2023 and has held it in 9 quarters since. The position peaked at $31.1K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Allworth Financial held 8,202 shares of Rocket Pharmaceuticals worth $28.1K as of Q2 2026.
  • Allworth Financial sold 498 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.66K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2929 holding.
  • Allworth Financial first reported a position in Rocket Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Allworth Financial's Rocket Pharmaceuticals position peaked at $31.1K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.